GHRP-6 (5mg x 10), CJC-1295 no DAC (5mg x 10)

GHRP-6 and CJC-1295 no DAC (Mod GRF 1-29) are synthetic research peptides commonly used together in experimental models to investigate growth hormone axis regulation and pituitary signaling mechanisms. GHRP-6 is a hexapeptide growth hormone secretagogue that binds the growth hormone secretagogue receptor (GHS-R1a), activating Gq/PLC-dependent calcium signaling pathways involved in GH release. CJC-1295 no DAC is a stabilized analog of growth hormone–releasing hormone (GHRH 1-29) that activates the GHRH receptor, stimulating adenylate cyclase and cAMP-mediated signaling. Preclinical studies demonstrate that combined GHS-R1a agonists and GHRH analogs are used to study synergistic somatotropic signaling, hypothalamic–pituitary feedback, and peptide-mediated endocrine regulation.